Grove Collaborative (NYSE: GROV), which completed a merger transaction with Virgin Group II in June 2022, announced this afternoon that it will implement a 1-for-5 reverse split of its common stock.
The company gained shareholder approval for the reverse stock split at a special meeting held yesterday and will be effective after market close on June 5. GROV’s common stock will trade on a post-split basis when the market opens on June 6.
At the effective time, every five issued and outstanding shares of GROV’s common stock will be converted into one share of common stock. The reverse stock split will reduce the number of shares of class A common stock issued and outstanding from approximately 129 million to 26 million, and the number of shares of class B common stock issued and outstanding from approximately 50 million to 10 million.
As a result of the reverse stock split, all outstanding public warrants to purchase GROV’s class A common stock will also be proportionately adjusted. Correspondingly, the exercise price per share of class A common stock attributable to such warrants prior to the reverse stock split has been proportionately increased from $11.50 to $57.50.
Additionally, the number of shares of GROV’s class A common stock subject to the public warrants will be decreased by five times, to an aggregate of 1,610,000 shares.
Grove Collaborative intends to use this reverse stock split to increase the market price per share of common stock to enhance its ability to regain compliance with the NYSE and to improve the marketability and liquidity of its common stock. In December 2022, just six months after the company went public, Grove received a notice from the NYSE that it was no longer in compliance with the stock exchange’s continued listing standards around minimum average share price.
If the price of GROV’s class A common stock remains above $1 per share for 30 trading days following the effective time of the reverse stock split, then Grove will be deemed to have regained compliance with the NYSE.
At the SPAC of Dawn The SPAC world is set to get its newest member later today when Launch Two (NASDAQ:LPBBU) begins trading having priced its $200 million IPO overnight. The technology SPAC is the first to IPO this quarter and comes after the newfound SPAC issuance momentum appeared to throttle down slightly in September,...
Launch Two Acquisition Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LPBBU”, Tuesday, October 8, 2024. The new SPAC’s primary search focus will be on technology and software infrastructure companies whose products and services target financial services, real estate and...
Oaktree III Life Sciences (NASDAQ:OACCU) has filed for a $175 million SPAC with some of the most aggressively team-friendly terms seen so far in the second half of 2024. The new SPAC’s units contain 1/5 warrants and the trust is not set to be overfunded. Only the warrantless Cantor Equity Partners (NASDAQ:CEP) has IPO’d so...
At the SPAC of Dawn SPACs are set to have a sleepy start to their post-Rosh Hashanah week with no votes on the docket until Wednesday. Three SPACs are to hold extension votes that day and Clover Leaf (OTC:CLOE) will try again to close its combination with Kustom Entertainment after several adjournments on Friday. In...
Terms Tracker for the Week Ending October 4, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This week was much, much heavier on the S-1 filings. There were five new SPACs filed along with six amended S-1 registration statements making good...